ENDPOINTS News Drug Discovery Day

UNIQUE INSIGHTS. Join ENDPOINTS Drug Discovery Day to hear from Serán's CEO Dan Smithey and three C-level industry leaders as they discuss challenges and insights for transitioning programs from discovery to development. Register free here.

WHAT THEY ARE TALKING ABOUT: Accelerating and streamlining the discovery of both small molecules and biologics is challenging. One of the toughest parts of that process is transitioning your most promising programs into the clinic — it's the time when innovators often feel alone and under pressure to prove efficacy before they run out of resources. But it needn’t be such a lonely journey. ENDPOINTS and Orientation Marketing have assembled three leading discovery and development partners to provide insights on how collaboration can help you reach your endpoints faster and more efficiently.

‍